- Home
- ENLV vs FLGC Comparison
ENLV vs FLGC Comparison
Compare ENLV & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- FLGC
- Stock Information
- Founded
- ENLV 2005
- FLGC 2019
- Country
- ENLV Israel
- FLGC United States
- Employees
- ENLV N/A
- FLGC N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- ENLV Health Care
- FLGC Health Care
- Exchange
- ENLV Nasdaq
- FLGC Nasdaq
- Market Cap
- ENLV 20.7M
- FLGC 17.3M
- IPO Year
- ENLV 1995
- FLGC 2021
- Fundamental
- Price
- ENLV $0.98
- FLGC $0.58
- Analyst Decision
- ENLV Strong Buy
- FLGC Strong Buy
- Analyst Count
- ENLV 2
- FLGC 3
- Target Price
- ENLV $10.00
- FLGC $5.00
- AVG Volume (30 Days)
- ENLV 63.0K
- FLGC 167.1K
- Earning Date
- ENLV 06-13-2025
- FLGC 05-13-2025
- Dividend Yield
- ENLV N/A
- FLGC N/A
- EPS Growth
- ENLV N/A
- FLGC N/A
- EPS
- ENLV N/A
- FLGC N/A
- Revenue
- ENLV N/A
- FLGC $59,505,000.00
- Revenue This Year
- ENLV N/A
- FLGC $4.28
- Revenue Next Year
- ENLV N/A
- FLGC N/A
- P/E Ratio
- ENLV N/A
- FLGC N/A
- Revenue Growth
- ENLV N/A
- FLGC N/A
- 52 Week Low
- ENLV $0.81
- FLGC $0.42
- 52 Week High
- ENLV $1.84
- FLGC $2.11
- Technical
- Relative Strength Index (RSI)
- ENLV 53.70
- FLGC 52.41
- Support Level
- ENLV $0.87
- FLGC $0.49
- Resistance Level
- ENLV $0.91
- FLGC $0.63
- Average True Range (ATR)
- ENLV 0.06
- FLGC 0.06
- MACD
- ENLV 0.01
- FLGC 0.02
- Stochastic Oscillator
- ENLV 90.31
- FLGC 76.19
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.